We Are

A clinical-stage biotech accelerating treatment development for unmet medical needs.

Drug Development

ULTRA - PURE CANNABINOIDS
Powered By Real World Evidence
Novel Formulation
Medical Indication
Dose Optimisation
Safety Trials
Pivotal Trials
Approval
EMD-RX5
Over the Counter
Psychological Distress
EMD-RX5
Over the Counter
Irritable Bowel Syndrome
EMD-RX7
Prescription
Multiple Medical Conditions
OTHERS IN DEVELOPMENT
Prescription
Multiple Medical Conditions

New Drug Discovery

MDMA - LIKE MEDICINE PROGRAMS
Ongoing Library Expansion
Program
Medical Indication
Discovery
Pre-Clinical
Phase 1
Pivotal Trials
Approval
Program 01
HIGHER POTENCY MDMA
e.g. Drug-assisted psychotherapy
Program 02
SELECTED BRAIN TARGETS
e.g. Parkinson's
Program 03
SELECTED NON-BRAIN TARGETS
e.g. Fibrotic Disease

Innovation

Technology
Description
Concept
Design
Submission
Approval
Launch
OPENLY
REMOTE HEALTH TRACKER
Vital Signs Tracked Via Smartphone CameraCLASS 2A MEDICAL DEVICE
0
%
FDA approvals where real-world evidence (RWE) was provided, and growing.
0
+
Unique data points collected per patient.
$
0
T USD
Trillion USD cost of chronic disease and mental health per year in the US.

For Investors

Ours is a collaborative vision and venture. We’re bringing people and partners together for the greater good: patients, clinicians, researchers, medical innovators and, of course, investors.

Call 08 6559 2800Contact